0001493152-24-043506.txt : 20241104 0001493152-24-043506.hdr.sgml : 20241104 20241104160241 ACCESSION NUMBER: 0001493152-24-043506 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241104 DATE AS OF CHANGE: 20241104 EFFECTIVENESS DATE: 20241104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mach5 Therapeutics, Inc. CENTRAL INDEX KEY: 0002018014 ORGANIZATION NAME: IRS NUMBER: 991673201 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-528600 FILM NUMBER: 241423381 BUSINESS ADDRESS: STREET 1: 650 PONCE DE LEON AVE STREET 2: STE. 300 #2347 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 404-487-8769 MAIL ADDRESS: STREET 1: 650 PONCE DE LEON AVE STREET 2: STE. 300 #2347 CITY: ATLANTA STATE: GA ZIP: 30308 D 1 primary_doc.xml X0708 D LIVE 0002018014 Mach5 Therapeutics, Inc. 650 PONCE DE LEON AVE STE. 300 #2347 ATLANTA GA GEORGIA 30308 404-487-8769 DELAWARE None None Corporation true 2023 Patrick J. Crutcher c/o Mach5 Therapeutics, Inc. 650 Ponce De Leon Ave Ste. 300 #2347 Atlanta GA GEORGIA 30308 Executive Officer Director Justin DiMartino c/o Mach5 Therapeutics, Inc. 650 Ponce De Leon Ave Ste. 300 #2347 Atlanta GA GEORGIA 30308 Executive Officer Director Biotechnology Decline to Disclose 06b false 2024-10-24 false true false 0 19929508 19179509 749999 false 15 0 0 0 true The Company will use the proceeds from the sale of the shares for product development and other general corporate purposes. false Mach5 Therapeutics, Inc. /s/ Patrick J. Crutcher Patrick J. Crutcher Chief Executive Officer 2024-11-04